SBIR/STTR Research Award

High-throughput single-cell transfection system for gene editing and isogenic iPS cell line generation

Award identifier 38fb4e71de44cb4e82cd7a4295e85f736d56d6a8f5bcdfb9c6aca93b66d1ad03Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$149,470

Program and phase

SBIR · Phase I

Award year

2018

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
INFINITESIMAL, LLC
Proposal award date
2018-08-01
Contract end date
2019-07-31
UEI
Not reported
Solicitation number
PA17-302
Topic code
400

Research abstract

InfinitesimalLLCSBIR Phase I ProposalProject Summary Induced pluripotent stem cellsiPSCshave become a prominent model for the understanding of genetic diseasesThe introduction of specific point mutations using the CRISPR Cassystem in iPSCs having the same genetic background results in isogenic cell lines that are invaluable to study disease mechanisms and for future personalized therapiesHowevercurrent methods for iPSC gene editing and cell line generation based on bulk electroporationrequire a lot of manual stepsare lengthyhave poor efficiencyrequire large amount of starting material of both cells and transfectantand are not amenable to multiplexingThereforenew and automated multiplexed systems that will enable unprecedented levels of gene editing and monoclonal isogenic cell line generation by dramatically reducing the cost per cell line as a result of automationtransfection precisionand minute amounts of reagent necesary per experimental condition are highly neededTo achieve this we propose the creation of the CellFabTM systeman integrated platform that will enable highthroughput single cell transfection of iPSCs using awell plate formatAfter transfection and growtheach colonyresulting from a single iPSC per wellwill be easily picked for screening and expansionThe CellFabTM system will include an inverted microscope with fluorescence and phase contrast capabilitiesa motorized stage and an image recognition algorithm for automated localization of individual iPSCs plated in awell plateCells will be transfected automatically using a vertical glass micropipettecontaining the transfectant and a platinum electrodeand a proprietary contact detection algorithmIn Phase IIthe system will include automated micropipette change and cleaning of the pipette housing and embedded electrodeThe specific aims for this proposal are the followingDesign and fabrication of the integrated system for high throughput single cell electroporationImage recognition software and contact algorithm will allow automated cell localization and transfection using a vertically positioned glass micropipetteGeneration of iPSC isogenic cell lines using the newly fabricated instrumentTwo gene engineering strategiescommonly used in cell line generationwill be assayed and comparedone using the CRISP Cassystem to knock out and knock in a specific geneand the other integrating a reporter gene employing a plasmid DNAGenerated cell lines will be expanded for analysis and the precision and efficiency of the CellFabTM system will be evaluatedThe successful completion of these aims will lead to the first integrated system for high throughput isogenic cell line generationwith multiplexed gene editingfor disease modeling and pharmacological studiesThis system is designed to interface with commercially available multiplexed systemsallowing automation of the whole procedurefrom dispensing to subculture InfinitesimalLLC SBIR Phase I ProposalProject Narrative The project is aimed at the development of the CellFabTM systeman integrated platform that will enable high throughput and automated single cell transfection of induced pluripotent stem cells and other adherent cells for biomedical studiesThe CellFabTM system is designed and engineered to achieve a paradigm shift in efficiency during multiplexed gene editingisogenic cell line generationand pharmacological studies necessary for the development of new therapiesBeing designed to interface with commercially available multiplexed systemsthe CellFabTM will allow unprecedented levels of automation of the protocols used in cell line generationfrom single cell dispensing to subculture DNA profiling of the genetically modified colonies

Technology keywords

Not reported

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.